Hostname: page-component-84b7d79bbc-c654p Total loading time: 0 Render date: 2024-07-30T13:29:48.219Z Has data issue: false hasContentIssue false

Anticholinergics: the consensus statement

Published online by Cambridge University Press:  02 January 2018

Jean Antoine Boodhoo
Affiliation:
Lucy Baldwin Hospital Olive Grove Stourport-on-Severn Hereford and Worcester
Martin Sandler
Affiliation:
Lucy Baldwin Hospital Olive Grove Stourport-on-Severn Hereford and Worcester
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1990 

References

Johnson, D. A. W. (1978) Prevalence and treatment of drug induced extrapyramidal symptoms. British Journal of Psychiatry, 132, 2730.CrossRefGoogle Scholar
Johnstone, E. C., Crow, J. J., Ferrier, I. N. et al (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychological Medicine, 13, 513527.CrossRefGoogle ScholarPubMed
McClelland, H. A., Blessed, G., Bhate, S. et al (1974) The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients. British Journal of Psychiatry, 124, 151159.CrossRefGoogle ScholarPubMed
McDonal, C. E. (1981) Haloperidol and laryngeal dystonia. American Journal of Psychiatry, 138, 12621263.CrossRefGoogle Scholar
Moss, H. B. & Green, A. (1982) Neuroleptic associated dysphagia confirmed by oesophageal manometry. American Journal of Psychiatry, 139, 515516.Google Scholar
Van Putten, T. (1974) Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry, 31, 6772.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.